样本编号 | SAMC2792200 |
---|---|
外部数据库编号 | GSA-Human: HRS849538 |
样品名称 | P14_T_B |
样本标题 | Human esophageal carcinoma |
样品类型 | Human sample |
物种名称 | Homo sapiens |
描述信息 | Patient14_Tumor tissue_Before Treatment |
样本属性 | *该样本包含更多受控访问信息,请通过GSA-Human系统申请项目HRA004740数据获取。 |
发布日期 | 2023-06-16 |
项目编号 | PRJCA016745 |
提交者 | Qiang Lu (luqiang@fmmu.edu.cn) |
提交单位 | Air Force Medical University |
提交日期 | 2023-06-18 |
资源名称 | 描述 |
---|---|
GSA-Human (1) | - |
HRA004740 (Controlled Access) | This study enrolled 22 patients diagnosed with stage II to IV ESCC, of whom 20 underwent neoadjuvant tislelizumab combined with chemotherapy before surgical removal and two were treated with camrelizumab plus chemotherapy before surgery. The dataset performed single-cell transcriptomic data of a total of 259,003 cells derived from 22 baseline and 24 post-NAT treatment samples of 22 stage II/III resectable ESCC patients. |